213 related articles for article (PubMed ID: 28561907)
1. Clinical significance of epithelial-to-mesenchymal transition in laryngeal carcinoma: Its role in the different subsites.
Mezi S; Chiappetta C; Carletti R; Nardini A; Cortesi E; Orsi E; Piesco G; Di Gioia C
Head Neck; 2017 Sep; 39(9):1806-1818. PubMed ID: 28561907
[TBL] [Abstract][Full Text] [Related]
2. [Expression of E-cadherin, N-cadherin, β-catenin and their clinical significance in laryngeal carcinoma].
Song PP; Qian XY; Zhou H; Shen XH; Liu DD; Feng AN; Gao X
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 51(6):440-5. PubMed ID: 27345880
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma.
Luo W; Fang W; Li S; Yao K
Int J Cancer; 2012 Oct; 131(8):1863-73. PubMed ID: 22307379
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-Mesenchymal Transition Markers β-catenin, Snail, and E-Cadherin do not Predict Disease Free Survival in Prostate Adenocarcinoma: a Prospective Study.
Ipekci T; Ozden F; Unal B; Saygin C; Uzunaslan D; Ates E
Pathol Oncol Res; 2015 Sep; 21(4):1209-16. PubMed ID: 26037169
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
6. The prognostic role of E-cadherin and β-catenin overexpression in laryngeal squamous cell carcinoma.
Greco A; De Virgilio A; Rizzo MI; Pandolfi F; Rosati D; de Vincentiis M
Laryngoscope; 2016 Apr; 126(4):E148-55. PubMed ID: 26511677
[TBL] [Abstract][Full Text] [Related]
7. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.
Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS
Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.
Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S
Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance of SOX4 and epithelial-mesenchymal transition markers in patients with laryngeal squamous cell carcinoma.
Zhang M; Li H; Han Y; Wang M; Zhang J; Ma S
Auris Nasus Larynx; 2021 Dec; 48(6):1167-1175. PubMed ID: 34001394
[TBL] [Abstract][Full Text] [Related]
10. [Estrogen receptor-β expression in laryngeal carcinoma: correlation with the expression of epithelial-mesenchymal transition specific biomarkers].
Mu L; Gu J; Zhang Y; Liang Y; Wang C; Li W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 May; 29(10):921-4. PubMed ID: 26596009
[TBL] [Abstract][Full Text] [Related]
11. Cyr61/CCN1 overexpression induces epithelial-mesenchymal transition leading to laryngeal tumor invasion and metastasis and poor prognosis.
Liu Y; Zhou YD; Xiao YL; Li MH; Wang Y; Kan X; Li QY; Lu JG; Jin DJ
Asian Pac J Cancer Prev; 2015; 16(7):2659-64. PubMed ID: 25854342
[TBL] [Abstract][Full Text] [Related]
12. The prognostic role of the epithelial-mesenchymal transition markers E-cadherin and Slug in laryngeal squamous cell carcinoma.
Cappellesso R; Marioni G; Crescenzi M; Giacomelli L; Guzzardo V; Mussato A; Staffieri A; Martini A; Blandamura S; Fassina A
Histopathology; 2015 Oct; 67(4):491-500. PubMed ID: 25684546
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor-beta expression in human laryngeal carcinoma: correlation with the expression of epithelial-mesenchymal transition specific biomarkers.
Goulioumis AK; Fuxe J; Varakis J; Repanti M; Goumas P; Papadaki H
Oncol Rep; 2009 Nov; 22(5):1063-8. PubMed ID: 19787222
[TBL] [Abstract][Full Text] [Related]
14. The role of biological markers of epithelial to mesenchymal transition in oesophageal adenocarcinoma, an immunohistochemical study.
Prins MJ; Ruurda JP; Lolkema MP; Sitarz R; Ten Kate FJ; van Hillegersberg R
J Clin Pathol; 2015 Jul; 68(7):529-35. PubMed ID: 25855799
[TBL] [Abstract][Full Text] [Related]
15. Syndecan-1, Epithelial-Mesenchymal Transition Markers (E-cadherin/β-catenin) and Neoangiogenesis-related Proteins (PCAM-1 and Endoglin) in Colorectal Cancer.
Mitselou A; Galani V; Skoufi U; Arvanitis DL; Lampri E; Ioachim E
Anticancer Res; 2016 May; 36(5):2271-80. PubMed ID: 27127133
[TBL] [Abstract][Full Text] [Related]
16. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition markers in the differential diagnosis of gastroenteropancreatic neuroendocrine tumors.
Galván JA; Astudillo A; Vallina A; Fonseca PJ; Gómez-Izquierdo L; García-Carbonero R; González MV
Am J Clin Pathol; 2013 Jul; 140(1):61-72. PubMed ID: 23765535
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of epithelial-mesenchymal transition markers in prostate cancer.
Figiel S; Vasseur C; Bruyere F; Rozet F; Maheo K; Fromont G
Hum Pathol; 2017 Mar; 61():26-32. PubMed ID: 27818287
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of E-cadherin, β-catenin and vimentin protein expression using quantitative immunohistochemistry in nasopharyngeal carcinoma patients.
Hao D; Phan T; Jagdis A; Siever JE; Klimowicz AC; Laskin JJ; Thomson TA; Rose MS; Petrillo SK; Magliocco AM; Lau HY
Clin Invest Med; 2014 Oct; 37(5):E320-30. PubMed ID: 25282138
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-mesenchymal transition and clinicopathological correlation in craniopharyngioma.
Qi ST; Zhou J; Pan J; Zhang C; Silky C; Yan XR
Histopathology; 2012 Oct; 61(4):711-25. PubMed ID: 23551434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]